Androgen receptor epigenetic variations influence early follicular phase gonadotropin levels

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 12, 2010, Pages 1557-1563

  Laisk, Triin ^a,b   Haller Kikkatalo, Kadri ^a   Laanpere, Margit ^a   Jakovlev, Ülle ^c   Peters, Maire ^a,b   Karro, Helle ^a   Salumets, Andres ^a,b,d  

^a UNIVERSITY OF TARTU   (Estonia)

^b Competence Centre on Reproductive Medicine and Biology ^*  (Estonia)

^c East Tallinn Central Hospital   (Estonia)

^d Centre for Infertility Treatment and Medical Genetics   (Estonia)

Author keywords

Androgen receptor; Ovarian reserve; PCOS; POF; X chromosome inactivation

Indexed keywords

ANDROGEN RECEPTOR; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE;

ADULT; ALLELE; ARTICLE; CAG REPEAT; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIGENETICS; FEMALE; FOLLICULAR PHASE; GENE; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; OVARIAN RESERVE; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

ADULT; ALLELES; CASE-CONTROL STUDIES; EPIGENESIS, GENETIC; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GONADOTROPINS; HUMANS; LUTEINIZING HORMONE; MICROSATELLITE REPEATS; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRIMARY OVARIAN INSUFFICIENCY; RECEPTORS, ANDROGEN; REFERENCE VALUES; RISK ASSESSMENT; X CHROMOSOME INACTIVATION;

EID: 78649244092     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016349.2010.526182     Document Type: Article

References (29)

1. Batista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Bremner WJ, et al. Effects of aging on menstrual cycle hormones and endometrial maturation. Fertil Steril. 1995;64:492-9.
2. Sharara FI, Beatse SN, Leonardi MR, Navot D, Scott Jr RT. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test. Fertil Steril. 1994;62:257-62.
3. Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest. 1975;55:699-706.
4. Meskhi A, Seif MW. Premature ovarian failure. Curr Opin Obstet Gynecol. 2006;18:418-26.
5. Fassnacht W, Mempel A, Strowitzki T, Vogt PH. Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. Curr Med Chem. 2006;13:1397-410.
6. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med. 1995;98:33S-39S.
7. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853-61.
8. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10:107-17.
9. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994;22:3181-6.
10. Puck JM, Willard HF. X inactivation in females with X-linked disease. N Engl J Med. 1998;338:325-8.
11. The Rotterdam ESHRE/ASRM-sponsored PCOS workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.
12. Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L. Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care. 2002;25:1217-22. (Pubitemid 41071175)
13. Saare M, Belousova A, Punab M, Peters M, Haller K, Ausmees K, et al. Androgen receptor gene haplotype is associated with male infertility. Int J Androl. 2008;31:395-402.
14. Sugawa F, Wada Y, Maruyama T, Uchida H, Ishizuka B, Ogata T. Premature ovarian failure and androgen receptor gene CAG repeat lengths weighted by X chromosome inactivation patterns. Fertil Steril. 2009;91:649-52.
15. Billig H, Furuta I, Hsueh AJ. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology. 1993;133:2204-12.
16. Sato K, Uehara S, Hashiyada M, Nabeshima H, Sugawara J, Terada Y, et al. Genetic significance of skewed X-chromosome inactivation in premature ovarian failure. Am J Med Genet A. 2004;130 A: 240-4.
17. Yoon SH, Choi YM, Hong MA, Kang BM, Kim JJ, Min EG, et al. X chromosome inactivation patterns in patients with idiopathic premature ovarian failure. Hum Reprod. 2008;23:688-92.
18. Bione S, Benedetti S, Goegan M, Menditto I, Marozzi A, Ferrari M, et al. Skewed X-chromosome inactivation is not associated with premature ovarian failure in a large cohort of Italian patients. Am J Med Genet A. 2006;140:1349-51.
19. Pu D, Wu J, Liu J. Skewed X chromosome inactivation may be not associated with premature ovarian failure. Gynecol Endocrinol. 2010;26:423-8.
20. Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:161-5.
21. Mifsud A, Ramirez S, Yong EL. Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metab. 2000;85:3484-8.
22. Hickey TE, Legro RS, Norman RJ. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:2789-91.
23. Burger LL, Haisenleder DJ, Aylor KW, Dalkin AC, Prendergast KA, Marshall JC. Regulation of luteinizing hormone-beta and follicle-stimulating hormone (FSH)-beta gene transcription by androgens: testosterone directly stimulates FSH-beta transcription independent from its role on follistatin gene expression. Endocrinology. 2004;145:71-8.
24. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab. 2004;89:6208-17.
25. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000;275:39523-8.
26. Otsuka F, Shimasaki S. A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology. 2002;143:4938-41.
27. Kline J, Kinney A, Levin B, Kelly A, Yu CY, Brown S, et al. X-chromosome inactivation and ovarian age during the reproductive years. Fertil Steril. 2006;85:1488-95.
28. Calvo RM, Asuncion M, Sancho J, San Millan JL, Escobar-Morreale HF. The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. J Clin Endocrinol Metab. 2000;85:1735-40.
29. Chang RJ, Katz SE. Diagnosis of polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28:397-408.